N. Fine Overview

  • Primary Position
  • Chief Executive...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

N. Fine General Information

Biography

Mr. N. Scott Fine serves as Chief Executive Officer at Cyclo Therapeutics. He has been a Director of the Company since February 2014 and became our Chief Executive Officer on September 14, 2015. From 2004 until 2014, he was a principal at Scarsdale Equities, an investment banking firm located in New York City. He has been involved in investment banking for over 35 years, working on a multitude of debt and equity financings, buy and sell side M&A, strategic advisory work and corporate restructurings. Much of his time has been focused on transactions in the healthcare and consumer products area. He has led global transactions in healthcare, including medical devices, generic pharmaceuticals, and genetics. He also worked with The Tempo Group of Jakarta, Indonesia. He was Chairman of the Board of The Global Virus Network (GVN), and he also was the lead investment banker on the initial public offering of Green Mountain Coffee Roasters, Inc. and Central European Distribution Corporation ("CEDC"), a multi-billion-dollar alcohol company. He continued his involvement with CEDC serving as a director from 1996 until 2014, during which time he led the CEDC Board in its successful efforts in 2013 to restructure the company through a pre-packaged Chapter 11 process whereby CEDC was acquired by the Russian Standard alcohol group. Recently, he served as Vice Chairman and Chairman of the Restructuring Committee of Pacific Drilling from 2017 to 2018 where he successfully led the independent directors to a successful reorganization. He also served as sole director of Better Place Inc. from 2013 until 2015. In his role there, he successfully managed the global wind down of the company in a timely and efficient manner which was approved by both the Delaware and Israeli Courts. He currently serves on the board of directors of Kenon Holdings Ltd. (NYSE: KEN). He also devotes time to several non-profit organizations, including through his service on the Board of Trustees for the IWM American Air Museum in Britain. He has been a guest lecturer at Ohio State University's Moritz School of Law and Fordham University Law School.

Contact Information

Primary Position
Chief Executive Officer & Board Member, Cyclo Therapeutics
Gender
Male
Phone
+1 (386)
Address
  • 6714 North West 16th Street
  • Suite B
  • Gainesville, FL 32653
  • United States
+1 (386)

N. Fine Positions (1)

Firm name Firm type Title Location Industry Since
Cyclo Therapeutics Company Chief Executive Officer & Board Member Gainesville, FL Biotechnology

N. Fine Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Cyclo Therapeutics Biotechnology Publicly Held Corporation Gainesville, FL
Kenon Holdings Holding Companies Publicly Held Corporate Backed or Acquired Singapore, Singapore

N. Fine Lead Partner on Deals (1)

N. Fine has been the lead partner on 1 deal. Their latest deal was with Applied Molecular Transport, a biotechnology company. The deal was made for on 27-Dec-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Applied Molecular Transport 27-Dec-2023 Merger/Acquisition Completed Biotechnology Menlo Park, CA

N. Fine Network (16)

Board Members (11)

Name Company Representing Location From
William Conkling Cyclo Therapeutics Rafael Holdings Gainesville, FL
Randall Toig Cyclo Therapeutics Self Gainesville, FL
Kenon Holdings Self Singapore, Singapore
Cyclo Therapeutics Cyclo Therapeutics Gainesville, FL
Kenon Holdings Self Singapore, Singapore

Portfolio Executives (5)

Name Company Role Deal date Location
Bittoo Kanwar Applied Molecular Transport Chief Medical Officer 27-Dec-2023 Menlo Park, CA
Randall Mrsny Ph.D Applied Molecular Transport Co-Founder, Chief Science Officer & Board Member 27-Dec-2023 Menlo Park, CA
Applied Molecular Transport Chief Technology Officer, Technology 27-Dec-2023 Menlo Park, CA
Applied Molecular Transport Chief Executive Officer & Chairman 27-Dec-2023 Menlo Park, CA
Applied Molecular Transport Chief Financial Officer, Finance & Chief Accounting Officer, Accounting 27-Dec-2023 Menlo Park, CA

N. Fine FAQs

  • Who is N. Fine?

    Mr. N.

  • How much does N. Fine typically invest?

    N. Fine's median deal size is .

  • What is N. Fine’s main position?

    N. Fine’s primary position is Chief Executive Officer & Board Member.

  • How many active board seats does N. Fine hold?

    N. Fine holds 2 board seats including Cyclo Therapeutics and Kenon Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »